BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahmadpanah M, Pezeshki R, Soltanian AR, Jahangard L, Dürsteler KM, Keshavarzi A, Brand S. Influence of adjuvant clonidine on mania, sleep disturbances and cognitive performance - Results from a double-blind and placebo-controlled randomized study in individuals with bipolar I disorder during their manic phase. J Psychiatr Res 2022;146:163-71. [PMID: 34990968 DOI: 10.1016/j.jpsychires.2021.12.035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Qi HX, Xiao X, Li T, Li M. New "drugs and targets" in the GWAS era of bipolar disorder. Bipolar Disord 2023. [PMID: 36633396 DOI: 10.1111/bdi.13295] [Reference Citation Analysis]
2 Bartoli F, Callovini T, Cavaleri D, Crocamo C, Riboldi I, Aguglia A, De Fazio P, Martinotti G, D’agostino A, Ostuzzi G, Barbui C, Carrà G, STAR Network Depot Investigators. Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study. Eur Arch Psychiatry Clin Neurosci 2022. [DOI: 10.1007/s00406-022-01522-5] [Reference Citation Analysis]
3 Merizalde Torres M, Castan Campanera E, Pifarré Paredero J. Clonidine reduces the need for antipsychotics in conduct disorders associated with intellectual disability and mental illness: A case series. Revista de Psiquiatría y Salud Mental 2022. [DOI: 10.1016/j.rpsm.2022.09.004] [Reference Citation Analysis]
4 Henry PH, Dantz B. Sublingual Dexmedetomidine vs Placebo and Acute Agitation Associated With Bipolar Disorder. JAMA 2022;328:213-4. [PMID: 35819431 DOI: 10.1001/jama.2022.8352] [Reference Citation Analysis]